Table 2 Comparison of antimicrobial therapies and treatment outcomes between CRKP-BSI and CSKP-BSI patients
Treatment and outcomes | Total (n = 114) | CRKP (n = 33) | CSKP (n = 81) | p-value |
|---|---|---|---|---|
Appropriate empirical antimicrobial therapy | 78(68.4) | 9(27.3) | 69(85.2) | <0.001 |
LOS after BSI onset,Days, median (IQR) | 18.5(9–31) | 24(9.5–51) | 15(8.5–28) | 0.066 |
Total LOS,days, median (IQR) | 31.5(19.75–62.75) | 50(28–83) | 24(16.5–51) | 0.001 |
Mortality rate | ||||
 Crude 28-day mortality n(%) | 26(22.8) | 11(33.3) | 15(18.5) | 0.087 |
 Crude in-hospital mortality n(%) | 30(26.3) | 14(42.4) | 16(19.8) | 0.013 |
 Attributable 28-day mortality n(%) | 24(21.1) | 11(33.3) | 13(16.0) | 0.04 |
 Attributable in-hospital mortality n(%) | 28(24.6) | 14(42.4) | 14(24.6) | 0.005 |